Today the Pharma headlines were………………
* French company Sanofi-Aventis, planning to launch a generic version of its own anti clotting blockbuster known commonly as Plavix, thereby helping it to combat the copycat drugs approved by European regulatory authorities.....
* On the Other hand Sandoz (Generic arm of Novartis) has got approval for its Biosimilar for Somatropin in Japanese market and according to company releases it is going to launch 10 generic drugs every year in Japanese market in the coming decade.....After Novartis I am expecting more news from GSK's generic arm.
* For the past 2 Quarter we have seen major M&A activity from Japanese end. Recently Koreans have been into many small size M&A activity , Today Arigene Co., Ltd. From south korea which is into related medical equipments business announced that it is planning to acquire Trimeris, Inc, USA, which is into viral infection treatment, Its drug FUZEON® a new class of anti-HIV drugs called fusion inhibitors, is already approved in U.S., Canada and European Union. The overall deal is for $81 Million. There is lot more M&A going to happen at Asian front :)
No comments:
Post a Comment